Cormorant Asset Management, LP ARRIVENT BIOPHARMA INC Transaction History
Cormorant Asset Management, LP
- $1.43 Billion
- Q3 2024
Number of Shares
585,462
Previous 515,000
13.68%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%